Why MDLN rose on Nov 4
Up 18% on Nov 4, a up day for the market: the S&P 500 rose 2%, 71% of stocks rose, and medical device stocks a median 7%.
- Its Nov 4 results:
MDLN's Quality Score rose 5 points on Wed, Nov 4, to 8. Its price climbed back above its average of the last 200 days.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 18% on Nov 4, a up day for the market: the S&P 500 rose 2%, 71% of stocks rose, and medical device stocks a median 7%.
| The chart | Above every average |
| Latest filing | 8-K, Nov 4 |
ReportYesterday morning: the results are out. Raised its outlook for the year. Past reports ›
Wed Nov 4Medline Reports Third Quarter and Nine Months 2026 Results
Tue Nov 17: Jefferies 17th Annual London Global…Investor conference · date confirmed.
1 more date ahead: the IPO anniversary, for Pro members.
After its last 4 reports it closed -1.3% on average, higher 1 of 4 times.
Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. MDLN scores 8 today, against a median of 3 over its last 20 recorded sessions.
MDLN is #32 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 32 |
Cash and short-term investments: MDLN $2.68B, SOLV $403M, ICUI $298M.
Expected to report Wed Feb 24, before the open (in 111 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
“This was primarily driven by existing customer growth and implementation of new customer signings from 2025 and includes an $11 million increase related to an adjustment of customer repayment amounts.”
MDLN's results filing gives no sales by line in a table we read.
| Measure | Figure |
|---|---|
| Organic sales growth | 10.0% to 10.5% |
“Third quarter 2026 Adjusted EBITDA¹ increased 11.8% to $960 million, compared to $859 million in the third quarter 2025, primarily driven by higher net sales and net IEEPA tariff refund benefits, partially offset by higher operating expenses and customer mix.”
From its results filing (SEC filing · Nov 4)
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Nov 4, 2026 | +9.6% | +18.4% | open |
| Aug 5, 2026 | -11.3% | -12.8% | -16.6% |
| May 6, 2026 | -5.0% | -7.3% | -14.9% |
Sales grew every year from 2023 to 2025, to $28B.
One insider bought $171K across 1 filing, and 3 insiders sold $3.5B across 20 filings, in the last 6 months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: MDLN is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Listed on Nasdaq on Dec 17, 2025, and is 35% above its $29 offer price now. The offer price is from Massive's IPO calendar.
“As a result of our integrated business model, our competitors include both other leading med-surg product manufacturers and distributors.”
MDLN scores 8 today, which Breakaway calls Average. It is #32 of 85 in Medical Devices by Quality Score, with 5 of 14 chart checks firing. Up 18% on Nov 4, a up day for the market: the S&P 500 rose 2%, 71% of stocks rose, and medical device stocks a median 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
MDLN scores 8 today, which Breakaway calls Average (6 to 10). That is #32 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind MDLN's 8.
One insider bought $171K across 1 filing, and 3 insiders sold $3.5B across 20 filings, in the last 6 months. The newest is GIC Private Ltd, 10% owner, who sold $275M on Oct 8. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.